Esophageal Cancer Clinical Trial

Volume Outcome Relationships and Effects

Summary

This is a retrospective analysis to assess if high-volume hospital facilities experience greater or lesser rates of incidence in patients with esophageal cancer than low-volume facilities.

View Full Description

Full Description

This is a retrospective analysis to assess if high-volume hospital facilities experience greater or lesser rates of incidence in patients with esophageal cancer than low-volume facilities.

The relationship between volume and outcomes has been proven in pancreatic cancer. Similar to pancreatic cancer, esophageal cancer historically has a bad prognosis. Esophageal cancer is typically asymptomatic, resulting in an advanced stage at the time of diagnosis. Additionally, it also has a significantly high morbidity and mortality. Therefore, it is crucial to determine volume-outcome relationships in esophageal cancer. This study aims to elucidate what these findings may entail by evaluating the impact that the volume-outcome relationship has on treatment assessment in esophageal cancer patients.

The purpose of the study is to evaluate the outcomes of esophageal cancer resection in patients in high volume (more than 5 esophagectomy performed per year) and low volume (less than 5 esophagectomy performed per year) hospital facilities. Furthermore, this paper will assess the outcomes of neoadjuvant and adjuvant therapy in esophageal cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

esophageal cancer

Exclusion Criteria:

No esophageal cancer

Study is for people with:

Esophageal Cancer

Estimated Enrollment:

30

Study ID:

NCT06343597

Recruitment Status:

Recruiting

Sponsor:

Methodist Health System

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Methodist Richardson Medical Center
Richardson Texas, 75082, United States More Info
Crystee Cooper, DHEd
Contact
214-947-1280
[email protected]
Zaid Haddadin, MS
Contact
2149471280
[email protected]
Dhiresh Jeyarajah, MD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Esophageal Cancer

Estimated Enrollment:

30

Study ID:

NCT06343597

Recruitment Status:

Recruiting

Sponsor:


Methodist Health System

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.